Health Catalyst, Inc. (HCAT)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 150M 300M 450M Q3 '21: 230.5M Q4 '21: 241.9M Q1 '22: 254.2M Q2 '22: 265.2M Q3 '22: 271.8M Q4 '22: 276.2M Q1 '23: 282M Q2 '23: 284.6M Q3 '23: 290M Q4 '23: 295.9M Q1 '24: 296.8M Q2 '24: 299.5M Q3 '24: 302.1M Q4 '24: 306.6M Q1 '25: 311.3M Q2 '25: 316.1M Q3 '25: 316.1M Q4 '25: 311.1M Q1 '26: 302.5M Q2 '26: 292.2M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit TTM

0 35M 70M 105M Q3 '21: 79.1M Q4 '21: 80M Q1 '22: 81.8M Q2 '22: 83.8M Q3 '22: 85.4M Q4 '22: 84.9M Q1 '23: 87M Q2 '23: 86.6M Q3 '23: 88.8M Q4 '23: 89.6M Q1 '24: 90.7M Q2 '24: 92.9M Q3 '24: 95.1M Q4 '24: 99.3M Q1 '25: 97.6M Q2 '25: 98M Q3 '25: 99.1M Q4 '25: 101.2M Q1 '26: 100.6M Q2 '26: 98.9M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Income TTM

-270M -180M -90M 0 90M 180M 270M Q3 '21: -137.8M Q4 '21: -143.7M Q1 '22: -143.7M Q2 '22: -144.6M Q3 '22: -148M Q4 '22: -140M Q1 '23: -150.6M Q2 '23: -152M Q3 '23: -130.9M Q4 '23: -126.9M Q1 '24: -114.8M Q2 '24: -96M Q3 '24: -85.1M Q4 '24: -69.8M Q1 '25: -67.2M Q2 '25: -88.5M Q3 '25: -92.3M Q4 '25: -160.9M Q1 '26: -247.2M Q2 '26: -246.5M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income TTM

-300M -200M -100M 0 100M 200M 300M Q3 '21: -147.2M Q4 '21: -153.2M Q1 '22: -147.3M Q2 '22: -144.9M Q3 '22: -150.6M Q4 '22: -137.4M Q1 '23: -148.1M Q2 '23: -147.3M Q3 '23: -123.6M Q4 '23: -118.1M Q1 '24: -105.5M Q2 '24: -86.4M Q3 '24: -79.1M Q4 '24: -69.5M Q1 '25: -72.7M Q2 '25: -100.1M Q3 '25: -107.6M Q4 '25: -178M Q1 '26: -265.3M Q2 '26: -264.8M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue TTM

0 60M 120M 180M Q3 '21: 117M Q4 '21: 124.4M Q1 '22: 131M Q2 '22: 135.6M Q3 '22: 138.8M Q4 '22: 143M Q1 '23: 147.4M Q2 '23: 152.2M Q3 '23: 157.6M Q4 '23: 164.1M Q1 '24: 164.3M Q2 '24: 164.9M Q3 '24: 165.5M Q4 '24: 165.8M Q1 '25: 170.5M Q2 '25: 172.9M Q3 '25: 169.1M Q4 '25: 159.5M Q1 '26: 151.6M Q2 '26: 144.7M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow TTM

-45M -30M -15M 0 15M 30M 45M Q4 '19: -32.2M Q1 '20: -43.7M Q2 '20: -36.1M Q3 '20: -35.1M Q4 '20: -26.1M Q1 '21: -12.5M Q2 '21: -16.6M Q3 '21: -17.5M Q4 '21: -23.1M Q1 '22: -18.8M Q2 '22: -23.6M Q3 '22: -30.2M Q4 '22: -35.3M Q1 '23: -42M Q2 '23: -44M Q3 '23: -28.9M Q4 '23: -33.1M Q1 '24: -17.2M Q2 '24: -4M Q3 '24: -955K Q1 '20 Q4 '20 Q3 '21 Q2 '22 Q1 '23 Q4 '23 Q3 '24

Free Cash Flow TTM

-60M -40M -20M 0 20M 40M 60M Q4 '19: -34.2M Q1 '20: -45.5M Q2 '20: -37.8M Q3 '20: -36.7M Q4 '20: -33.9M Q1 '21: -25.8M Q2 '21: -31.7M Q3 '21: -33.8M Q4 '21: -33.6M Q1 '22: -23.7M Q2 '22: -26.4M Q3 '22: -32.6M Q4 '22: -37.4M Q1 '23: -44.2M Q2 '23: -46.4M Q3 '23: -30.3M Q4 '23: -34.3M Q1 '24: -18.3M Q2 '24: -5M Q3 '24: -2.4M Q1 '20 Q4 '20 Q3 '21 Q2 '22 Q1 '23 Q4 '23 Q3 '24

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 30M 60M 90M Q1 '20: 37.1M Q2 '20: 38.1M Q3 '20: 40.3M Q1 '21: 43.9M Q2 '21: 44.9M Q3 '21: 49M Q1 '22: 53.2M Q2 '22: 53.7M Q3 '22: 54.3M Q1 '23: 55.5M Q2 '23: 56M Q3 '23: 56.7M Q1 '24: 58.6M Q2 '24: 59.3M Q3 '24: 60.4M Q1 '25: 68.6M Q2 '25: 69.6M Q3 '25: 70.4M Q1 '26: 72.6M Q2 '26: 74M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-4.50 -3.00 -1.50 0.00 1.50 3.00 4.50 Q3 '21: -3.31 Q4 '21: -3.23 Q1 '22: -3.12 Q2 '22: -2.94 Q3 '22: -2.96 Q4 '22: -2.66 Q1 '23: -2.72 Q2 '23: -2.68 Q3 '23: -2.23 Q4 '23: -2.09 Q1 '24: -1.84 Q2 '24: -1.49 Q3 '24: -1.34 Q4 '24: -1.15 Q1 '25: -1.15 Q2 '25: -1.51 Q3 '25: -1.59 Q4 '25: -2.56 Q1 '26: -3.74 Q2 '26: -3.70 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.